Recently, James Price, the CEO of ExamWorks (NYSE: EXAM) bought 14,500 shares of the company on the first day of March at an average price of nearly $14 per share, with a total transaction value of more than $200,000. For more than a year, ExamWorks has experienced a significant rise in its share price, from $6.50 to $15.25. Should investors follow James Price into ExamWorks at more »
Investopedia indicates that short selling is a technique used when an investor is sure a stock is going to decline and wants to profit from the decline. A short attack is more neferious.
Any seasoned investor is likely familiar with a short attack: a report based on bits of truth, wrapped it in fear and innuendo, and bathed in unsubstantiated statements presented as facts. The attacker presents this dubious information more »
As we get closer to the health care reform legislation becoming effective, many people are looking for prospective healthcare plays. Many health care companies have seen a pretty marked increase in volume and volatility as of late as news sheds light as to how particular provisions of the new law will affect various healthcare subsectors. In this article, I analyze key companies that a may see an outsized impact due more »